Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CpG island promoters often lack canonical core promoter elements such as the TATA box, and have dispersed transcription initiation sites. Despite the prevalence of CpG islands associated with mammalian genes, the mechanism of transcription initiation from CpG island promoters remains to be clarified. Here we investigate the mechanism of transcription initiation of the CpG island-associated gene,
insulin-degrading enzyme
(
IDE
).
IDE
is ubiquitously expressed, and has dispersed transcription initiation sites. The
IDE
core promoter locates within a 32-bp region, which contains three CGGCG repeats and a nuclear respiratory factor 1 (NRF-1) binding motif. Sequential mutation analysis indicates that the NRF-1 binding motif is critical for
IDE
transcription initiation. The NRF-1 binding motif is functional, because NRF-1 binds to this motif in vivo and this motif is required for the regulation of
IDE
promoter activity by NRF-1. Furthermore, the NRF-1 binding site in the
IDE
promoter is conserved among different species, and dominant negative NRF-1 represses endogenous
IDE
expression. Finally,
TATA-box binding protein
(
TBP
) is not associated with the
IDE
promoter, and inactivation of
TBP
does not abolish
IDE
transcription, suggesting that
TBP
is not essential for
IDE
transcription initiation. Our studies indicate that NRF-1 mediates
IDE
transcription initiation in a
TBP
-independent manner, and provide insights into the potential mechanism of transcription initiation for other CpG island-associated genes.
...
PMID:Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner. 2287 Feb 79